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Summary We present the third case of Niemann–Pick dis-
ease type C without neurological symptoms. The patient was
a 53-year-old woman without significant prior health prob-
lems who died of acute pulmonary embolism. Autopsy find-
ings of hepatosplenomegaly, lymphadenopathy and ceroid-
rich foam cells raised the suspicion of the visceral form of
acid sphingomyelinase deficiency (Niemann–Pick disease
type B; NPB) or a much rarer disorder, variant adult visceral
form of Niemann–Pick disease type C (NPC). To verify the
histopathological findings, SMPD1, NPC1 and NPC2 genes
were analysed. Two novel sequence variants, c.1997G > A
(S666N) and c.2882A > G (N961S) were detected in the
NPC1 gene. No pathogenic sequence variants were found
either in the SMPD1 gene mutated in NPB or in NPC2 gene.
The pathogenicity of both NPC1 variants was supported by
their location in regions important for the protein function.
Both variations were not found in more than 300 control al-
leles. Identified sequence variations confirm the diagnosis
of the extremely rare adult visceral form of Niemann–Pick
disease type C, which is otherwise dominated by neurovis-
ceral symptoms. Although only three patients have been re-
ported, this (most probably underdiagnosed) form of NPC
should be considered in differential diagnosis of isolated hep-
atosplenomegaly with foam cells in adulthood.
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Summary Homozygosity for D409H has been associated
with a unique type III subtype of the disease with a phenotype
dominated by severe cardiovascular involvement, whereas
neurological findings, if present, are restricted to oculomo-
tor apraxia and features such as visceromegaly are either
minimal or absent. Using PCR amplification followed by re-
striction enzyme analysis, 3 patients (1 Greek, 2 Albanians)
were identified with the D409H/D409H genotype. All shared
a very severe early-onset neurological phenotype that classi-
fied them as type II. Amplification and sequencing of the full
coding region of the GBA gene revealed that all three patients
were homozygous not only for D409H but also for H255Q.
Both mutations were present on the same allele, as shown by
analysis of the parental DNA. The double D409H+H255Q
allele was found in heterozygosity in Greek, Bulgarian and
Argentinian patients but was not identified in any Spanish
patients carrying the D409H mutation.
Communicating editor: Irene Maire
H. Michelakakis () · M. Moraitou · E. Dimitriou
Department of Enzymology and Cellular Function, Institute of
Child Health, Athens, Greece
e-mail: inchildh@otenet.gr
R. Santamaria · G. Sanchez · D. Grinberg · L. Vilageliu
Department de Genetica, Facultat de Biologia, Universitat de
Barcelona, Spain
L. Gort · A. Chabas · S. Fotopoulos
Institut de Bioquimica Clinica, Corporacio Sanitaria Clinic,
Barcelona, Spain
M. Dassopoulou
NICU, “Alexandra” Hospital Athens, and “Ag. Sophia” Children’s
Hospital, Athens, Greece
Electronic Supplementary Material
Supplementary material is available for this article at
http://dx.doi.org/10.1007/s10545-006-0316-x
Springer
